{"doi":"10.1101/2022.10.18.512699","title":"A germline-targeting chimpanzee SIV envelope glycoprotein elicits a new class of V2-apex directed cross-neutralizing antibodies","abstract":"Abstract HIV-1 and its SIV precursors share a broadly neutralizing antibody (bNAb) epitope in variable loop 2 (V2) at the envelope glycoprotein (Env) trimer apex. Here, we tested the immunogenicity of germline-targeting versions of a chimpanzee SIV (SIVcpz) Env in human V2-apex bNAb heavy-chain precursor-expressing knock-in mice and as chimeric simian-chimpanzee immunodeficiency viruses (SCIVs) in rhesus macaques (RMs). Trimer immunization of knock-in mice induced V2-directed NAbs, indicating activation of V2-apex bNAb precursor-expressing mouse B cells. SCIV infection of RMs elicited high-titer viremia, potent autologous tier 2 neutralizing antibodies, and rapid sequence escape in the canonical V2-apex epitope. Six of seven animals also developed low-titer heterologous plasma breadth that mapped to the V2-apex. Antibody cloning from two of these identified multiple expanded lineages with long heavy chain third complementarity determining regions that cross-neutralized as many as 7 of 19 primary HIV-1 strains, but with low potency. Negative stain electron microscopy (NSEM) of members of the two most cross-reactive lineages confirmed V2 targeting but identified an angle of approach distinct from prototypical V2-apex bNAbs, with antibody binding either requiring or inducing an occluded-open trimer. Probing with conformation-sensitive, non-neutralizing antibodies revealed that SCIV-expressed Envs as well as some primary HIV-1 Envs adopted a more open conformation, thereby exposing a conserved V2 epitope that is occluded in closed SIVcpz and HIV-1 Env trimers. These results expand the spectrum of V2-apex targeted antibodies that can contribute to neutralization breadth and identify novel SIV Env platforms for further development as germline-targeting and immunofocusing immunogens. One sentence summary A cryptic V2 epitope in occluded-open HIV and SIV Env trimers is the target of a new class of V2-directed cross-neutralizing antibodies.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2022,"id":312611,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9551,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":280551,"name":"Ronnie M. Russell","orcid":"0000-0003-1484-4207","position":1,"is_corresponding":false},{"id":283217,"name":"Wenge Ding","orcid":null,"position":2,"is_corresponding":false},{"id":280552,"name":"Weimin Liu","orcid":"0000-0001-7508-0947","position":3,"is_corresponding":false},{"id":376418,"name":"Yingying Li","orcid":"0000-0002-0237-6824","position":4,"is_corresponding":false},{"id":268925,"name":"Kshitij Wagh","orcid":"0000-0001-7552-6582","position":5,"is_corresponding":false},{"id":87305,"name":"Daniel Wrapp","orcid":"0000-0002-0538-9647","position":6,"is_corresponding":false},{"id":1010058,"name":"Rumi Habib","orcid":"0000-0002-2812-8263","position":7,"is_corresponding":false},{"id":726136,"name":"Ashwin N. Skelly","orcid":"0000-0002-1565-3376","position":8,"is_corresponding":false},{"id":280542,"name":"Ryan S. Roark","orcid":"0000-0003-0586-103X","position":9,"is_corresponding":false},{"id":575868,"name":"Scott Sherrill-Mix","orcid":"0000-0002-8955-8072","position":10,"is_corresponding":false},{"id":280546,"name":"Shuyi Wang","orcid":"0000-0001-6831-9323","position":11,"is_corresponding":false},{"id":283214,"name":"Juliette Rando","orcid":null,"position":12,"is_corresponding":false},{"id":280039,"name":"Emily Lindemuth","orcid":null,"position":13,"is_corresponding":false},{"id":1010490,"name":"Kendra Cruickshank","orcid":null,"position":14,"is_corresponding":false},{"id":1010059,"name":"Young-Hoon Park","orcid":"0000-0003-4016-8652","position":15,"is_corresponding":false},{"id":344068,"name":"Rachel Baum","orcid":"0000-0002-8227-7462","position":16,"is_corresponding":false},{"id":280553,"name":"Andrew Connell","orcid":"0000-0002-9393-3074","position":17,"is_corresponding":false},{"id":523778,"name":"Hui Li","orcid":"0000-0003-2600-4838","position":18,"is_corresponding":false},{"id":103727,"name":"Elena Giorgi","orcid":"0000-0003-2968-1033","position":19,"is_corresponding":false},{"id":809176,"name":"Ge Song","orcid":"0009-0006-5116-7208","position":20,"is_corresponding":false},{"id":241572,"name":"Shilei Ding","orcid":"0000-0003-1895-5131","position":21,"is_corresponding":false},{"id":241588,"name":"Andrés Finzi","orcid":"0000-0002-4992-5288","position":22,"is_corresponding":false},{"id":537905,"name":"Amanda Newman","orcid":"0000-0002-0277-7054","position":23,"is_corresponding":false},{"id":553751,"name":"Giovanna E. Hernandez","orcid":"0000-0001-5498-3469","position":24,"is_corresponding":false},{"id":756539,"name":"Emily Machiele","orcid":null,"position":25,"is_corresponding":false},{"id":267571,"name":"Derek W. Cain","orcid":"0000-0002-5988-6729","position":26,"is_corresponding":false},{"id":227359,"name":"Katayoun Mansouri","orcid":"0000-0001-6232-7330","position":27,"is_corresponding":false},{"id":4374,"name":"Mark G. Lewis","orcid":"0000-0001-7852-0135","position":28,"is_corresponding":false},{"id":103755,"name":"David C. Montefiori","orcid":"0000-0003-0856-6319","position":29,"is_corresponding":false},{"id":274230,"name":"Kevin Wiehe","orcid":"0000-0001-9933-9618","position":30,"is_corresponding":false},{"id":258350,"name":"S. Munir Alam","orcid":"0000-0003-0941-0703","position":31,"is_corresponding":false},{"id":229156,"name":"I‐Ting Teng","orcid":"0000-0002-4704-7100","position":32,"is_corresponding":false},{"id":105633,"name":"Peter D. Kwong","orcid":"0000-0003-3560-232X","position":33,"is_corresponding":false},{"id":294229,"name":"Raiees Andrabi","orcid":"0000-0001-8837-7520","position":34,"is_corresponding":false},{"id":469215,"name":"Laurent Verkoczy","orcid":"0000-0001-7497-6645","position":35,"is_corresponding":false},{"id":108980,"name":"Dennis R. Burton","orcid":"0000-0001-6711-9864","position":36,"is_corresponding":false},{"id":24197,"name":"Bette Korber","orcid":"0000-0002-2026-5757","position":37,"is_corresponding":false},{"id":230387,"name":"Kevin O. Saunders","orcid":"0000-0001-7399-7954","position":38,"is_corresponding":false},{"id":96347,"name":"Barton F. Haynes","orcid":"0000-0002-7643-9023","position":39,"is_corresponding":false},{"id":227358,"name":"Robert J. Edwards","orcid":"0000-0003-4446-1194","position":40,"is_corresponding":false},{"id":253820,"name":"George M. Shaw","orcid":"0000-0002-2338-4532","position":41,"is_corresponding":false},{"id":91120,"name":"Beatrice H. Hahn","orcid":"0000-0002-9400-9887","position":42,"is_corresponding":false},{"id":283215,"name":"Frédéric Bibollet‐Ruche","orcid":null,"position":0,"is_corresponding":true}],"reference_count":97,"raw_metadata":null,"created_at":"2026-07-19T00:33:36.072096Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}